Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor. (2017)
Attributed to:
Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.phrs.2017.02.023
PubMed Identifier: 28274851
Publication URI: http://europepmc.org/abstract/MED/28274851
Type: Journal Article/Review
Volume: 119
Parent Publication: Pharmacological research
ISSN: 1043-6618